Reference SummaryTang B, Nat Med 1998 Jul;4(7):802-7
Title |
Transforming growth factor-beta1 is a new form of tumor suppressor with true haploid insufficiency. | ||||
Authors |
Tang B; Bottinger EP; Jakowlew SB; Bagnall KM; Mariano J; Anver MR; Letterio JJ; Wakefield LM | ||||
Journal |
Nat Med | ||||
Volume |
4 | ||||
Issue |
7 | ||||
Year |
1998 | ||||
Pages |
802-7 | ||||
Abstract |
Components of the transforming growth factor-beta (TGF-beta) signal pathway function as classic tumor suppressors, but the role of the TGF-betas themselves is less clear. Here we show that mice heterozygous for deletion of the TGF-beta1 gene express only 10-30% of wild-type TGF-beta1 protein levels. Although grossly normal, these mice have a subtly altered proliferative phenotype, with increased cell turnover in the liver and lung. Treatment of these mice with chemical carcinogens resulted in enhanced tumorigenesis when compared with wild-type littermates. However, tumors in the heterozygous mice did not lose the remaining wild-type TGF-beta1 allele, indicating that the TGF-beta1 ligand is a new form of tumor suppressor that shows true haploid insufficiency in its ability to protect against tumorigenesis. | ||||
Links |
J:78174 – MGI References 9662371 – National Library of Medicine/PubMed |
||||
Strain Notes
|
|||||
| Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
|---|---|---|---|---|---|
| B6.129S6-Tgfb1tm1N/+ | Liver hepatocellular adenoma | Liver |
0 |
||
| B6.129S6-Tgfb1tm1N/+ | Liver hepatocellular adenoma |
|
Liver |
observed - 20 |
|
| B6.129S6-Tgfb1tm1N/+ | Liver hepatocellular adenoma |
|
Liver |
0 - 29 |
|
| C57BL/6NCr | Liver hepatocellular adenoma | Liver |
0 |
||
| C57BL/6NCr | Liver hepatocellular adenoma |
|
Liver |
0 |
|
| C57BL/6NCr | Liver hepatocellular adenoma |
|
Liver |
0 - 9.1 |
|
| B6.129S6-Tgfb1tm1N/+ | Liver hepatocellular carcinoma | Liver |
0 |
||
| B6.129S6-Tgfb1tm1N/+ | Liver hepatocellular carcinoma |
|
Liver |
0 |
|
| B6.129S6-Tgfb1tm1N/+ | Liver hepatocellular carcinoma |
|
Liver |
0 - 25 |
|
| C57BL/6NCr | Liver hepatocellular carcinoma | Liver |
0 |
||
| C57BL/6NCr | Liver hepatocellular carcinoma |
|
Liver |
0 - 9.1 |
|
| C57BL/6NCr | Liver hepatocellular carcinoma |
|
Liver |
0 |
|
| B6.129S6-Tgfb1tm1N/+ | Liver hepatocellular tumor |
|
Liver |
44 |
|
| C57BL/6NCr | Liver hepatocellular tumor |
|
Liver |
36 |
|
| B6.129S6-Tgfb1tm1N/+ | Liver hyperplasia | Liver |
0 |
||
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus adenoma | Lung - Alveolus |
5.3 |
||
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus adenoma |
|
Lung - Alveolus |
0 - observed |
|
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus adenoma |
|
Lung - Alveolus |
0 |
|
| C57BL/6NCr | Lung - Alveolus adenoma | Lung - Alveolus |
0 |
||
| C57BL/6NCr | Lung - Alveolus adenoma |
|
Lung - Alveolus |
0 |
|
| C57BL/6NCr | Lung - Alveolus adenoma |
|
Lung - Alveolus |
0 - 9.1 |
|
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus carcinoma | Lung - Alveolus |
0 |
||
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus carcinoma |
|
Lung - Alveolus |
0 - 29 |
|
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus carcinoma |
|
Lung - Alveolus |
0 - 4.8 |
|
| C57BL/6NCr | Lung - Alveolus carcinoma | Lung - Alveolus |
0 |
||
| C57BL/6NCr | Lung - Alveolus carcinoma |
|
Lung - Alveolus |
0 |
|
| C57BL/6NCr | Lung - Alveolus carcinoma |
|
Lung - Alveolus |
0 |
|
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus tumor |
|
Lung - Alveolus |
79 |
|
| B6.129S6-Tgfb1tm1N/+ | Lung - Alveolus tumor |
|
Lung - Alveolus |
52 |
|
| C57BL/6NCr | Lung - Alveolus tumor |
|
Lung - Alveolus |
60 |
|
| B6.129S6-Tgfb1tm1N/+ | Lung hyperplasia | Lung |
0 |